Inhibikase Therapeutics: Q2 Earnings Insights

Inhibikase Therapeutics IKT reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Inhibikase Therapeutics beat estimated earnings by 5.26%, reporting an EPS of $-0.18 versus an estimate of $-0.19.

Revenue was down $1.36 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 1.63% increase in the share price the next day.

Here's a look at Inhibikase Therapeutics's past performance:

To track all earnings releases for Inhibikase Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.